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Abstract
Background: Claims of and calls for evidence-informed policymaking pervade public health journals and the
literature of governments and global health agencies, yet our knowledge of the arrangements most conducive to
the appropriate use of evidence is incomplete and fragmented. Designing interventions to encourage evidence use
by policymakers requires an understanding of the processes through which officials access, assess and use research,
including technical and political factors related to evidence uptake, and the ways in which the policymaking
context can affect these processes. This review aims to systematically locate, synthesise and interpret the existing
qualitative work on the process of evidence use in public health policymaking, with the aim of producing an
empirically derived taxonomy of factors affecting evidence use.
Methods/design: This review will include primary qualitative studies that examined the use of research evidence
by policymakers to inform decisions about public health. To locate studies, we will search nine bibliographic
databases, hand-search nine public health and policy journals and scan the websites of relevant organisations and
the reference lists of previous reviews of evidence use in policymaking. Two reviewers will independently screen
studies, apply inclusion criteria and appraise the quality of included studies. Data will be coded inductively and
analysed using thematic synthesis. An augmented version of the CASP Qualitative Checklist will be used to appraise
included studies, and the CERQual tool will be used to assess confidence in the review’s findings. The review’s
results will be presented narratively and in tabular form. Synthesis findings will be summarised as a taxonomy of
factors affecting evidence use in public health policymaking. A conceptual framework explaining the relationships
between key factors will be proposed. Implications and recommendations for policy, practice and future research
will be discussed.
Discussion: This review will be the most comprehensive to date to synthesise the qualitative literature on evidence
use by public health policymakers and will be the first to apply a formal method of qualitative metasynthesis to this
body of evidence. Its results will be useful both to scholars of evidence use and knowledge translation and to
decision-makers and academics attempting to influence public health policy.
Keywords: Evidence-informed policy, Evidence-to-policy processes, Evidence use, Public health, Public health
policy, Qualitative evidence synthesis, Qualitative research
* Correspondence: benjamin.verboom@spi.ox.ac.uk
1Centre for Evidence-Based Intervention, Department of Social Policy and
Intervention, University of Oxford, Barnett House, 32 Wellington Square,
Oxford, OX1 3DW, UK
2Department of International Health, Johns Hopkins Bloomberg School of
Public Health, 615 North Wolfe Street, Baltimore, 21205, MD, USA
© 2016 Verboom et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Verboom et al. Systematic Reviews  (2016) 5:61 
DOI 10.1186/s13643-016-0240-6
Background
The recent popularisation of evidence-based medicine,
which calls for the explicit, judicious and conscientious use
of up-to-date research evidence in clinical decision-making,
has prompted discussion about the role of research evi-
dence in informing policy-level decision-making, leading to
calls for more systematic and appropriate evidence use by
actors involved in crafting public health policy.
Designing interventions to encourage the appropriate
use of evidence by public health policymakers requires
an understanding of the processes through which bu-
reaucrats and politicians access, assess and use evidence,
including the technical factors (i.e. barriers and facilitators)
related to evidence uptake. It also requires an appreciation
for the ideological nature of policymaking in general [1],
and (public) health policymaking in particular [2], and
the processes through which political factors can affect
whether and how evidence translates into policy [3].
Policy decisions related to the health of populations,
whether at the subnational, national or international level,
are likely to be particularly controversial and politically
charged. The ongoing debate about the extent to which
the state should be engaged in promoting public health
and access to health services [4, 5] and the often unequal
distribution of the benefits of population-level health in-
terventions [6] are just two reasons for this.
Policymaking inevitably involves (often controversial)
trade-offs between different values, priorities, and interests,
including considerations related to public opinion, expected
health outcomes, intervention cost, perceived fairness and
equity and ethics [7]. An understanding of how decision-
makers weigh up research evidence against these compet-
ing priorities is a prerequisite to developing strategies to en-
courage these actors to use evidence more appropriately.
A growing body of primary qualitative literature has
examined the role of research evidence in public health
decision-making [8]. However, previous efforts to sys-
tematically review this work [8–10] have primarily taken
an ‘aggregative’ or ‘synoptic’ approach, that is, they have
pooled and summarised data from existing primary
studies without reinterpreting reported findings across
studies to generate novel theoretical insights. The
evolving family of qualitative review methods collectively
termed ‘qualitative evidence synthesis’ or ‘qualitative meta-
synthesis’ [11] is defined by the production of ‘higher-level’
(sometimes called ‘third-order’ [12]) theoretical constructs
that ‘go beyond’ providing an aggregation of individual
study findings to more comprehensively explain phenom-
ena of interest. Importantly, qualitative metasynthesis in-
volves integrating findings from multiple qualitative studies
and, through considering the body of included study re-
ports as a whole, producing inferences and interpretations
that are not located in or derivable from any one included
research report [11].
In this review, we will apply the metasynthetic tech-
nique of thematic synthesis [13] to analyse and interpret
the existing qualitative work on the process of evidence
use in public health policymaking, with the aim of
producing an empirically derived taxonomy of factors
affecting this process. The specific objectives of this
review are:
1. To locate and synthesise all qualitative evidence on
the use of research evidence in public health
policymaking, including data on:
 Factors (e.g. barriers and facilitators) associated
with the (appropriate) use of evidence
 The process(es) through which evidence is
accessed, valuated (i.e. compared to competing
inputs) and applied to policymaking
 Policymaker perceptions of the (appropriate) role
of research evidence in public health policymaking
in general and their work in particular
2. Using the data obtained through the first objective,
to produce a taxonomy of the factors impacting upon
evidence-informed policymaking in public health
3. To preliminarily identify, through the examination
of subgroups of included studies, factors affecting
evidence use that may be dependent on the context
in which the activity of policymaking takes place
Methods/design
We explored the possibility of registering this protocol
in the PROSPERO database, but learned that (as of
early-2016) PROSPERO only accepts systematic reviews
with a ‘health-related outcome’. As our review does not
meet this criterion, it has not been registered in PROS-
PERO. However, we hope that the a priori publication of
this protocol serves some of the same purposes as regis-
tration, namely increasing transparency and reducing
the likelihood of bias and unnecessary duplication of
efforts [14].
Criteria for considering studies for this review
In this section, we outline the criteria against which
studies will be included or excluded from the review.
Briefly, in order to be included in the review, a study
must:
 Be a qualitative study, published or unpublished
 Examine policy activities, processes and/or decisions
in policy settings
 Report data concerning the use of research evidence
to inform decisions about public health
In the subsections that follow, we provide a more de-
tailed explanation of and rationale for these inclusion
criteria.
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Types of studies
This review will only include qualitative studies that re-
port primary data. For the purposes of this review, we
will use the following definition of ‘qualitative study’: a
study that uses qualitative methods both for data collec-
tion and data analysis. This definition is consistent with
that used in several recent qualitative syntheses [15–17]
and was cited as one useful definition in the Cochrane
Qualitative and Implementation Methods Group supple-
mentary guidance on qualitative evidence synthesis [18].
Methods of qualitative data collection include (but are
not limited to) interviews, focus groups and participant
observation methods, while methods of qualitative data
analysis include, for example, thematic analysis, content
analysis, discourse analysis and grounded theory ap-
proaches. This definition of qualitative study excludes, for
example, studies in which data were collected through in-
terviews or focus groups, but were analysed exclusively
through quantitative methods (e.g. tallies, descriptive sta-
tistics, etc.). We will include mixed methods studies that
used both qualitative and quantitative methods, provided
that it is possible extract data derived only from the quali-
tative methods.
We will not exclude studies according to the epis-
temological assumption(s) and/or theoretical tradition(s)
on which they were based. That is, we will include all
work within the broad ‘qualitative paradigm’.
Studies will not be excluded from the review on the
basis of any hierarchy of qualitative evidence or criteria
related to study quality. However, we recognise the
possibility that including all eligible qualitative studies
regardless of methodological quality may risk biasing
the review’s findings [19]. As described below, a qual-
ity appraisal tool will be applied to all included studies
prior to data analysis. Using sensitivity analysis (also
discussed below), we will assess the potential undue
influence of low scoring studies on our findings [20].
Studies will not be excluded on the basis of publication
status (e.g. type of publication), publication date or the
language in which the study was reported.
Types of settings and participants
This review will include studies reporting on policy
activities, decisions, and/or processes with an explicit
(though not necessarily exclusive) focus on public health
issues. Studies reporting data derived from human partici-
pants (i.e. via interviews, focus groups or observation, as
opposed to documents) will be included in the review if
their participants included policymakers engaged in such
activities. There is no universally accepted definition of
the population ‘policymakers’ [21, 22]. For the purposes
of this review, the population ‘policymakers’ includes
government officials of any rank who are either elected
(i.e. politicians) or appointed (i.e. civil servants, policy
advisors and/or bureaucrats), working at the sub-national
(e.g. local, state, provincial), national or international/global
(i.e. intergovernmental) levels. Consistent with previous re-
views [23, 24], we distinguish policymakers from managers
(i.e. program managers, healthcare executives, management
consultants, with supervisory and management responsibil-
ities in healthcare and public health organisations) and
service providers (i.e. front-line practitioners who typically
make decisions about individual patient care, including
physicians and nurses). Studies that exclusively include
managers and/or service providers will be excluded.
If there is any lack of clarity within study reports about
the role(s) of study participants and, as a consequence,
uncertainty about whether they fit this definition of
‘policymakers’, we will contact original study authors
for clarification.
Unlike in previous reviews of evidence use in public
health [10] and non-health sectors of policy [25], studies
will not be excluded on the basis of the country in which
the study was conducted. The rationale for this inclu-
siveness is to capture the potential influence on evidence
use of factors related to the political, economic and so-
cial context in which policymaking activities take place.
Subject matter of studies
To be eligible for inclusion, studies must explore the use
or reported use of some type of research evidence in pol-
icy processes and/or decisions related at least in part to
public health.
For the purposes of this review, public health policy
decisions are those taken with the explicit goal of pro-
moting the health of the population (whether at the
sub-national, national or international level). This excludes
policy decisions related to the provision of individual-level
clinical interventions, unless these have an explicitly stated
public health goal (as in the case of most immunisation
policies). However, recognising the now widely appreci-
ated importance of the social determinants of health [26]
and understanding that policy decisions made outside of
ministries and departments of public health, across a
variety of sectors (e.g. transport, housing, crime), can have
meaningful impacts on health [27], studies of policymakers
with non-health portfolios will be included if population
health, or the relationship between their decisions and pub-
lic health outcome(s), is an explicit focus of the research.
For this review, research evidence will be defined as
research produced by academic researchers and/or pub-
lished in academic journals. This definition is similar to
that used in a recent systematic review of evidence use
in non-health settings [25], whose authors found that
their original attempt to use a broader definition of re-
search evidence produced results so conceptually hetero-
geneous that a meaningful synthesis was unfeasible.
Included studies may examine the use of research evidence
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in general, or a specific category or ‘form’ of research
evidence, including, for example, reports of randomised
controlled trials, systematic reviews and/or meta-analyses
and evidence summaries or overviews of reviews.
Search methods for identification of studies
We plan to electronically search the following biblio-
graphic databases without restriction by date:
 Applied Social Sciences Index and Abstracts (ASSIA)




 International Bibliography of the Social Sciences (IBSS)
 MEDLINE
 SCOPUS
 Social Sciences Citation Index (SSCI)
 Worldwide Political Science Abstracts (WPSA)
Search strategies for each database have been designed
in consultation with an information retrieval specialist.
In general, the strategies prioritise sensitivity in order to
capture all studies relevant to the research question
without restriction on the basis of language, location or
publication status of the study. Where possible and ap-
propriate, we plan to use a qualitative study design filter
in order to enhance specificity [28, 29]. See Additional
file 1 for our MEDLINE search strategy.
We also plan to hand-search the following journals (or
specific sections thereof, where indicated) published
since the beginning of 2010:
 BMC Public Health (Sections: Global health; Health
policies, systems and management in high-income
countries; Health policies, systems and management
in low and middle-income countries)
 Evidence & Policy
 Health Policy
 Health Policy & Planning
 Health Research Policy and Systems
 Implementation Science
 Journal of Health Politics, Policy & Law
 Milbank Quarterly
 Social Science and Medicine
To supplement these sources, we will scan the ‘publi-
cations’ and/or ‘documents’ sections of the websites of
relevant foundations, agencies and organisations (e.g.
Evidence to Policy Initiative (E2Pi), University of California
at San Francisco) and the reference lists of our included
studies and of previous reviews of evidence use in policy-
making [3, 8–10, 25]. As needed, experts and authors of in-
cluded studies will be contacted to access unpublished data
of studies located through the above methods and to obtain
information about any as yet unpublished studies.
Data collection and analysis
In this section, we describe the planned methods for
selecting studies, extracting and managing data, assessing
the quality of included studies and confidence in the review
findings and analysing and presenting the review findings.
Selection of studies
Study screening and selection will be conducted according
to standard systematic review methods [30] using EndNote
X7 software (Thomson Reuters). Two reviewers will inde-
pendently screen all titles and abstracts. Full-text versions
of records deemed potentially relevant by at least one re-
viewer will be obtained for further review. Both reviewers
will then independently screen the full-text versions of all
potentially relevant articles for inclusion in the review. Any
disagreements will be resolved through conference and, if
necessary, deferral to a third reviewer. Reasons for the
exclusion of studies at the full-text review stage will be
recorded, tabulated and provided in an appendix to the
final review article.
Data extraction and management
There is no universally accepted approach to extracting
data for the purposes of qualitative metasynthesis. Strat-
egies vary from the very selective to the very inclusive.
In extremely inclusive approaches, the entire texts of in-
cluded papers are essentially treated as data, while in
more selective approaches, findings are only extracted
from included studies when they are explicitly supported
by direct quotations from study participants in the text
of the article [18]. This latter approach risks missing
findings that on the individual study level are perhaps of
secondary importance, but collectively may emerge as
important recurrent themes across studies. We will there-
fore adopt an approach emphasising inclusiveness, since
this review is interested in the full breadth of factors af-
fecting evidence use in public health policy.
Since the ‘informants’ in qualitative reviews are the
original study authors (not the studies’ participants), all
author interpretations of study results (in the form of
themes, categories, diagrams, tables, etc.) qualify as data
for this review [15, 18]. Adopting a version of Thomas
and Harden’s [13] approach, we will extract all data la-
belled by study authors as results/findings, etc. and dis-
cussion/conclusion(s)/interpretation(s), etc. Data will
be extracted verbatim from study papers directly into
NVivo-11 software (QSR International).
In addition to extracting results and discussion sections
into NVivo, the following information will be recorded for
each included study:
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 Basic study information (authors, title, year(s) of
data collection, year of publication)
 Brief summary of the study’s focus, phenomena of
interest, and theoretical/philosophical basis
 Study design (including sampling procedures) and
description of qualitative methods used (e.g.
interviews, observation, document analysis)
 Description of the study setting, policymaking
context, level of policymaking (i.e. subnational,
national or international/global) and country or
countries in which the activity of policymaking took
place (as well as the country’s income level at the
time of data collection according to the World Bank
country classification system)
 Description of participants (type of policymaker,
rank/title, gender, etc.)
BV will extract these data from all included studies
using a tabular data extraction form in Microsoft Excel;
a second reviewer will assess the extracted data for ac-
curacy against original study reports. Discordant inter-
pretations will be discussed and resolved. Persistent
disagreements will be resolved in consultation with PM.
These descriptive study-level data will be reported in a
summary table included in the final report and will be
used in exploratory sub-group analysis (discussed below).
Assessment of study quality
Study quality in this review will be assessed according to
an adapted version of the Critical Appraisal Skills Pro-
gramme’s (CASP) tool for appraising qualitative re-
search [31]. CASP is arguably the most ‘user-friendly’
of the widely used tools; however, in a comparative as-
sessment of three popular critical appraisal tools, CASP
was found wanting in terms of sensitivity to descriptive,
interpretive and theoretical validity [32]. To address
these limitations, we have augmented the CASP tool
with four items adapted from the Joanna Briggs Institute
Qualitative Assessment and Review Instrument [33]. The
adapted CASP instrument (Additional file 2) contains 12
items, all of which can be answered with either ‘Yes’, ‘No’,
or ‘Unclear’. For the purpose of aiding interpretation of
the review findings, included studies will be assigned an
overall score of ‘high’, ‘moderate’ or ‘low’ overall methodo-
logical quality according to a holistic reading of included
papers, guided by consideration of these 12 items. It is im-
portant to note that these items are not designed to yield
an overall numerical ‘score’ for the methodological quality
of studies. Rather, the questions are designed as prompts
to guide the reviewers in a critical reading of the studies.
Indeed, as there is no consensus on the relative weight
that should be ascribed to any individual characteristic of
study quality, the presentation of a simple summed score
of the tool’s items would risk being more misleading than
informative.
BV and a second reviewer will independently pilot the
adapted CASP instrument on a random sample of five
included studies. The results of the two reviewers’ as-
sessments will be compared and any discordant inter-
pretations of items will be discussed with the broader
review team to establish a consensus moving forward.
Following the pilot stage, BV and the second reviewer
will independently assess the quality of all included
studies. Disagreements will be discussed and resolved.
Persistent disagreements will be resolved by consulting
PM. Quality ratings assigned to each study, and the ra-
tionale for these decisions (including any disputes and
how they were resolved), will be explicitly detailed in
an appendix to the final report.
As mentioned above, the results of the quality assessment
will not be used to exclude studies from the review, but
quality ratings will be used to inform interpretation of the
data [34] and will be used in concert with the Confidence
in the Evidence from Reviews of Qualitative Research
(CERQual) tool to assess the confidence in the review’s
findings (discussed below).
As well, post hoc sensitivity analysis will be undertaken
to assess the potential influence of study quality on the re-
view’s findings. This approach is analogous to the sensitiv-
ity analyses commonly conducted in quantitative reviews
[20, 35]. We will estimate the robustness of the review’s
findings to the inclusion/exclusion of studies receiving a
‘low quality’ rating to test for the potential undue influ-
ence of severely methodologically flawed studies [36].
Data synthesis
Data will be analysed using NVivo-11 software according
to Thomas and Harden’s [13] method of qualitative
thematic synthesis. Thematic synthesis involves the
line-by-line coding of the text of included studies to
produce so-called descriptive themes within studies,
followed by the re-interpretation and synthesis of these
newly organised data across studies to produce higher-
order ‘analytical themes’ that ‘go beyond’ the findings
of the individual primary studies. This potential generation
of new theory via the production of higher order themes
represents a synthesis step hitherto not attempted in re-
views of evidence use in public health policymaking. No
themes will be specified a priori to guide the review. Ra-
ther, themes will be allowed to emerge inductively as we
interpret individual study data and synthesise data across
studies.
The synthesis procedure will follow the three stages of
thematic synthesis described by Thomas and Harden
[13], the first two of which take place concurrently: (1)
coding text, (2) developing descriptive themes and (3)
developing analytical themes.
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During the first and second stages, the data from each
included study will be considered in isolation. BV will
read and re-read the text of each study in NVivo-11 and
will develop codes to describe the meaning and content
of the text line by line. Sections of text (e.g. sentences)
may be assigned a single code or multiple codes. As codes
emerge and accumulate during this process, BV will or-
ganise them hierarchically, as appropriate, to develop
descriptive themes to explain the data. During this
stage, all of the text assigned to each code will periodically
be checked for interpretive consistency to determine
whether new codes are necessary and to contemplate
whether some codes should be collapsed. Throughout this
process, other team members will be consulted regularly
to discuss coding decisions and the validity of the emer-
ging list of descriptive themes, and amendments will be
made as necessary.
During the third stage of thematic synthesis, ‘higher
order’ analytical themes are developed from critical
examination of the aggregated descriptive themes de-
veloped in stage two [13]. At this point in the analysis,
BV will reconsider the set of data, now coded across
studies and organised into descriptive themes, and in-
terrogate it for newly emerging cross-study themes. As
in stage two, other team members will be consulted
regularly to discuss the appropriateness of decisions
related to the assignment of analytical themes. Following
consultations, amendments to themes will be made as ne-
cessary, and the data will be revisited and considered in
the context of any newly emergent themes. This iterative
process will continue until examination of the data ceases
to yield new analytical themes.
As the synthesis process progresses, interpretations of
the emerging themes will be summarised as a taxonomy
of ‘factors’ affecting evidence use in public health policy-
making, categorised according to the analytical themes.
As new findings emerge from the interrogation of the
data, the list of factors will be amended as appropriate.
An auditable ‘decision trail’ tracking the supporting
text for each theme, and the study/ies from which this
text was drawn, will be recorded in NVivo throughout
the process of data synthesis. Tracking (and transparently
reporting) the studies that contribute to each ‘finding’ of
the review will facilitate confidence assessments and
subgroup analysis (both discussed below) and will en-
hance the ease with which the review can be critiqued
and reproduced.
Assessment of confidence in review findings
The CERQual approach will be used to provide an as-
sessment of the level of confidence (certainty) in each of
the review’s findings [37]. In the context of qualitative
evidence synthesis, ‘confidence’ refers to the extent to
which a review finding can be considered a reasonable
representation of the phenomenon of interest; for ex-
ample, an assessment of high confidence would signify
that the phenomenon of interest is unlikely to differ sub-
stantially from the review finding. The CERQual tool,
which is currently under development, draws on the
principles used to develop the Grading of Recommenda-
tions, Assessment, Development and Evaluations (GRADE)
approach [38]. It emerged in 2010 to assist a World Health
Organization guideline development panel in using synthe-
sised qualitative evidence to inform their recommendations.
At least six other reviews [15, 39–43] have utilised the
CERQual approach or an earlier version of it.
Confidence is assessed at the level of the individual ‘re-
view finding’; that is, through the process described
below, each ‘finding’ from the synthesis will be assigned
a confidence rating. The current version of the CERQual
tool assesses confidence in the evidence on the basis of
(1) the methodological limitations of the studies that
contributed to each review finding, (2) the relevance of
the included studies to the review question, (3) the co-
herence of each review finding and (4) the adequacy of
the data contributing to each review finding. The
methodological limitations of included studies refer to
the extent to which there are problems in the design
or conduct of the primary studies that contributed evi-
dence to a review finding. The relevance of the included
studies to the review question refers to the extent to which
the review finding is applicable to the context (i.e., the
population, setting and phenomenon) in which the review
is interested. The coherence of a review finding refers to
the extent to which the ‘pattern’ that constitutes a review
finding is consistent across multiple individual studies (or,
alternatively, incorporates explanations for variations in
the finding across individual studies). The adequacy of
data refers to the richness (and ‘thickness’) and quantity of
data supporting a given review finding.
CERQual requires that review authors form what are
ultimately subjective judgements based on criteria that
are somewhat open to interpretation: there are no
straightforward, algorithmic criteria upon which to rate
studies in these four domains. For the purposes of this
review, assessments will be made as follows:
1. An assessment of the methodological limitations of
each review finding will be made on the basis of the
quality ratings assigned to individual studies that
contributed to that review finding (using the
adapted CASP tool; described above). That is, we
will take into consideration the assessed quality of all
studies tied to a given review finding and decide
whether or not each review finding was generally
drawn from well-conducted studies.
2. The data contributing to a review finding will be
deemed highly relevant when the contexts and
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phenomena of the primary studies underlying a
review finding are not substantively different from
the context and phenomena of interest in the
review. Relevant studies will be those explicitly and
centrally focused on research evidence use by public
health policymakers. Studies in which the use of
evidence is considered, but is peripheral to their
central focus, will be considered less relevant.
Similarly, studies in which public health is of
secondary concern to the policymakers will also be
deemed less relevant.
3. A review finding will be considered highly coherent
when it is manifested across multiple contexts
(i.e. studies) in a consistent pattern or where any
significant variation in the finding across studies is
plausibly explained by the finding itself (i.e. the
finding is coherently context-dependent). Findings
that are inconsistent and/or contradictory across
studies, and where contradictions and inconsistencies
are unexplained, will be deemed less coherent.
4. The adequacy of the data contributing to a finding
will be determined by assessing the number of
studies contributing to a finding, alongside the
perceived ‘richness’ and ‘thickness’ of the data
reported in those studies. A review finding that is
supported by several primary studies of moderate
richness/thickness and/or a few primary studies of
high richness/thickness will be rated as being
supported by adequate data. A finding that is
supported by only one or few primary studies of
moderate or low richness/thickness, or by any
number of studies with only low richness/
thickness, will be rated as being supported by less
adequate data.
After assessing each of the four components, we will
make a judgement about the overall confidence in each
review finding. Findings will be assessed as having ‘high’,
‘moderate’, ‘low’ or ‘very low’ confidence. The developers
of CERQual define these four levels of confidence as
follows:
 High confidence: It is highly likely that the review
finding is a reasonable representation of the
phenomenon of interest
 Moderate confidence: It is likely that the review
finding is a reasonable representation of the
phenomenon of interest
 Low confidence: It is possible that the review finding
is a reasonable representation of the phenomenon of
interest
 Very low confidence: It is not clear whether the
review finding is a reasonable representation of the
phenomenon of interest
BV and a second reviewer will independently apply the
CERQual tool to the review findings. The results of both
assessments will be compared and discordant assessments
discussed until consensus is achieved for each finding.
Any persistent disagreements on confidence ratings will
be resolved in consultation with PM. The final results of
the CERQual assessment will be reported in tabular form
(discussed below) and will be incorporated into the narra-
tive explanation of review’s results.
Subgroup analysis
As appropriate, we will perform subgroup analysis to
explore possible variation in the review’s findings accord-
ing to three categories of study-level characteristic:
 Type of qualitative method(s) used (e.g. interviews/
focus groups versus observation versus document
analysis)
 Policy context (i.e. subnational versus national
versus international/global)
 Economic context according to World Bank country
classifications (i.e. studies conducted in high-income
countries versus those conducted in either low-,
lower-middle-, or higher-middle-income countries)
Examining differences in findings according to the
qualitative methods used in included studies may help
to inform the design of future work in this area. For
instance, it is possible that more political and/or less
socially desirable characteristics of evidence use or non-
use are more difficult to capture using methods of self-
report (i.e. individual or group interviews) than through
analysis of policy documents or participant observation
methods. The content of our findings derived from each
of these methods may shed light on such discrepancies.
Exploring differences in findings across contexts could
improve our understanding of the nature of public
health evidence use at different governance levels and
in different economic contexts and could help to in-
form the specification of interventions to encourage
evidence-informed policymaking for different types of
policymakers. These results may be also used to gener-
ate hypotheses about context-specific evidence use for
future quantitative studies in this area. For example, these
results could inform subgroup analyses in future reviews of
the effectiveness of knowledge translation interventions for
policymakers.
Presentation of findings
The study design features, participant and setting
characteristics, data collection and analysis methods and
reported findings of all included studies will be sum-
marised in tabular form and described narratively.
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Results of the thematic synthesis and of the CERQual
assessments will be tabulated in a ‘summary of qualitative
findings table’. The review findings (factors affecting evi-
dence use) will be classified into categories, informed by
the analysis and listed in a table. A brief description of
each factor will be provided, along with each factor’s ‘con-
fidence’ rating. This exercise will produce an empirically
derived taxonomy of factors related to evidence use in
public health policy that can be interrogated and further
refined in future empirical work (both qualitative and
quantitative). The review’s findings will also be sum-
marised visually in a proposed conceptual framework
explaining the relationship between the key factors af-
fecting evidence use.
Reporting methods
This protocol was developed and reported according to
the Preferred Reporting Items for Systematic Reviews
and Meta-analyses (PRISMA)-P Statement for reporting
systematic review protocols [44]. See Additional file 3
for a completed PRISMA-P checklist. The review’s methods
and results will be reported according to the ENTREQ
(enhancing transparency in reporting the synthesis of
qualitative research) statement for reporting syntheses
of qualitative studies [45]. The final literature searches
employed will be reported using the STARLITE (sam-
pling strategy, type of study, approaches, range of years,
limits, inclusion and exclusions, terms used, electronic
sources) standards for reporting literature searches
[46], and search and screening results will be sum-
marised and presented using the flowchart described in
the PRISMA statement [47]. Any deviations from this
protocol will be recorded by BV and reported in the
final review report.
Discussion
Claims of and calls for evidence-informed policymaking
pervade public health journals and the literature of
governments and international agencies, yet our know-
ledge of the conditions and arrangements most condu-
cive to the appropriate use of evidence is incomplete
and fragmented. While much primary research has
been conducted to examine the factors affecting evi-
dence use by public health policymakers [8], this litera-
ture remains largely unsynthesised. This review will
be the most comprehensive to date to synthesise the
qualitative literature on evidence use by public health
policymakers and will be the first to apply a formal
method of qualitative metasynthesis to this body of
evidence. Its results will be useful both to scholars of
evidence use and knowledge translation and to deci-
sion-makers and academics attempting to influence
public health policy.
Additional files
Additional file 1: Sample search strategy - Strategy used to conduct
search in MEDLINE database (via OVID). (PDF 28 kb)
Additional file 2: Adapted CASP form - Tool that will be used to assess
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